Today: 10 June 2026
D-Wave Quantum (QBTS) stock slips premarket as $550 million Quantum Circuits deal spotlights dilution
9 January 2026
1 min read

D-Wave Quantum (QBTS) stock slips premarket as $550 million Quantum Circuits deal spotlights dilution

New York, Jan 9, 2026, 09:05 EST — Premarket

D-Wave Quantum Inc (QBTS) shares slid about 3.1% to $29.28 in premarket trading on Friday as investors digested the company’s agreement to buy Quantum Circuits in a $550 million cash-and-stock deal. The stock component will be based on a 10-day volume-weighted average price, with a collar of $22.30 to $39.03 per share, and the deal can be terminated if it isn’t completed by April 6, according to a filing with the .

The deal is notable because it takes D-Wave further into gate-model quantum computing, the “circuit” approach designed to run a wide range of algorithms. D-Wave is best known for quantum annealing, a more specialised method focused on optimisation problems.

That shift is what traders are paying for right now: a cleaner path from lab work to something that can be sold, faster, in a sector that’s long traded on milestones and timelines more than steady profits. The deal’s cash component and the stock collar push funding and dilution back to the forefront.

D-Wave said it expects the acquisition to close in late January, subject to conditions including U.S. antitrust review, and pitched it as a way to speed up its gate-model roadmap. Chief Executive Alan Baratz said that meant “bringing gate-model products and services to market in 2026,” while Quantum Circuits co-founder and chief scientist Rob Schoelkopf said “Fault-tolerant error-corrected quantum computing is within our reach.” D-Wave Quantum

“Error correction” is industry shorthand for methods designed to spot and repair mistakes that creep in when qubits — the basic units of quantum processors — get hit by noise. It’s one of the main obstacles to turning experimental machines into dependable tools.

Rivals including IonQ and Rigetti are also selling routes to gate-model systems, even as big tech groups bankroll their own architectures. For D-Wave, it comes down to whether it can juggle two tracks — annealing for near-term commercial work and gate-model for a broader future — without spreading capital and engineers too thin.

But the setup works both ways. If the shares slide toward the collar floor before closing, the company may have to issue more stock to hit the $300 million value, and any holdup in regulatory sign-off could push the timeline out.

Next up for investors: what D-Wave rolls out at its in Boca Raton, Florida, on Jan. 27-28, and whether the company can still stick to that late-January close.

Stock Market Today

  • 3 High ROE Stocks With Solid Balance Sheets Highlighted for Investors
    June 10, 2026, 9:01 AM EDT. Investors seeking stability amid inflation and geopolitical tensions may focus on companies with high return on equity (ROE) and robust balance sheets. Regis Resources (ASX:RRL) stands out with a 25.7% ROE, strong revenue from Australian gold projects, and forecasts of earnings growth above 20%. However, it faces risks from gold price fluctuations and project approvals. Aristocrat Leisure (ASX:ALL) features as a global gaming technology leader with substantial revenue streams and solid financial fundamentals. These stocks provide potential resilience against margin pressure and volatile input costs, offering a grounded starting point for quality-focused investment research.

Latest articles

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

10 June 2026
BlackBerry shares dropped 4.84% to $8.84 Tuesday and slid further to $8.42 premarket Wednesday, erasing part of a 49% rally as investors question whether QNX and Secure Communications growth can justify recent gains ahead of Q1 fiscal 2027 earnings on June 25; the stock is now down 14.5% from last week’s close.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
Nokia stock rises after Hisense patent deal ends litigation; investors watch next moves
Previous Story

Nokia stock rises after Hisense patent deal ends litigation; investors watch next moves

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
Next Story

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Go toTop